Looking For A Top Momentum Stock? Why Coherus Biosciences Inc (NASDAQ: CHRS) Is A Great Pick

Coherus Biosciences Inc (NASDAQ:CHRS) shares, rose in value on Tuesday, December 31, with the stock price down by -8.00% to the previous day’s close as strong demand from buyers drove the stock to $1.38.

Actively observing the price movement in the last trading, the stock closed the session at $1.50, falling within a range of $1.37 and $1.515. The value of beta (5-year monthly) was 0.693. Referring to stock’s 52-week performance, its high was $3.70, and the low was $0.66. On the whole, CHRS has fluctuated by 13.11% over the past month.

With the market capitalization of Coherus Biosciences Inc currently standing at about $146.27 million, investors are eagerly awaiting this quarter’s results, scheduled for in February.

Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 255.58M, with a low estimate of 36.42M and a high estimate of 58.9M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 43.88M.

Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CHRS’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a Hold.

The stock’s technical analysis shows that the price of CHRS currently trading nearly -12.21% and 18.68% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 47.98, while the 7-day volatility ratio is showing 8.60% which for the 30-day chart, stands at 13.09%. Furthermore, Coherus Biosciences Inc (CHRS)’s beta value is 0.81, and its average true range (ATR) is 0.16.

A comparison of Coherus Biosciences Inc (CHRS) with its peers suggests the former has fared considerably weaker in the market. CHRS showed an intraday change of -8.00% in last session, and over the past year, it shrunk by -58.56%%.

Data on historical trading for Coherus Biosciences Inc (NASDAQ:CHRS) indicates that the trading volumes over the past 10 days have averaged 2.43 and over the past 3 months, they’ve averaged 5.22 million. According to company’s latest data on outstanding shares, there are 115.21 million shares outstanding.

Nearly 4.03% of Coherus Biosciences Inc’s shares belong to company insiders and institutional investors own 66.08% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 31.07 million shares as on 2024-12-13, resulting in a short ratio of 3.23. According to the data, the short interest in Coherus Biosciences Inc (CHRS) stood at 3147.00 of shares outstanding as of 2024-12-13; the number of short shares registered in 2024-11-15 reached 33.04 million. The stock has fallen by -58.56% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CHRS stock heading into the next quarter.

Most Popular